Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Terns Pharmaceuticals Inc (TERN)
Terns Pharmaceuticals Inc (TERN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Terns Pharmaceuticals Inc 1065 EAST HILLSDALE BLVD. SUITE 100 FOSTER CITY CA 94404 USA

www.ternspharma.com P: 650-525-5535 F: 650-275-4395

Description:

Terns Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It engages in development of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis and other chronic liver diseases. Terns Pharmaceuticals Inc. is based in FOSTER CITY, Calif.

Key Statistics

Overview:

Market Capitalization, $K 462,844
Enterprise Value, $K 319,604
Shares Outstanding, K 61,795
Annual Sales, $ 0 K
Annual Net Income, $ -60,350 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -29,770 K
EBIT, $ -95,330 K
EBITDA, $ -94,220 K
60-Month Beta -0.82
% of Insider Shareholders 17.40%
% of Institutional Shareholders 98.26%
Float, K 51,043
% Float 82.60%
Short Volume Ratio 0.33

Growth:

1-Year Return -27.74%
3-Year Return -57.27%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.42 on 11/14/23
Latest Earnings Date 03/25/24
Earnings Per Share ttm -1.27
EPS Growth vs. Prev Qtr -68.00%
EPS Growth vs. Prev Year 4.55%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

TERN Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -30.99%
Return-on-Assets % -29.58%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 1.79
Book Value/Share 4.23
Interest Coverage -1.68
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar